<?xml version="1.0" encoding="UTF-8"?>
<ref id="B124-vaccines-07-00053">
 <label>124.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Zarubaev</surname>
    <given-names>V.V.</given-names>
   </name>
   <name>
    <surname>Beliaevskaia</surname>
    <given-names>S.V.</given-names>
   </name>
   <name>
    <surname>Sirotkin</surname>
    <given-names>A.K.</given-names>
   </name>
   <name>
    <surname>Anfimov</surname>
    <given-names>P.M.</given-names>
   </name>
   <name>
    <surname>Nebol’sin</surname>
    <given-names>V.E.</given-names>
   </name>
   <name>
    <surname>Kiselev</surname>
    <given-names>O.I.</given-names>
   </name>
   <name>
    <surname>Reĭkhart</surname>
    <given-names>D.V.</given-names>
   </name>
  </person-group>
  <article-title>In vitro and in vivo effects of ingavirin on the ultrastructure and infectivity of influenza virus</article-title>
  <source>Vopr. Virusol.</source>
  <year>2011</year>
  <volume>56</volume>
  <fpage>21</fpage>
  <lpage>25</lpage>
  <?supplied-pmid 22171473?>
  <pub-id pub-id-type="pmid">22171473</pub-id>
 </element-citation>
</ref>
